‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue

Original research
by
Clay, Simon et al

Release Date

2023

Geography

Australia

Language of Resource

English

Full Text Available

Yes

Open Access / OK to Reproduce

Yes

Peer Reviewed

Yes

Objective

The aim of this study was to explore what it is like to receive depot buprenorphine and to understand the motivations behind why people discontinue.

Findings/Key points

Participants cited 4 key reasons why they decided to discontinue depot buprenorphine:1) feeling forced into the program, 2) experiencing negative side-effects, 3) finding the treatment ineffective, and 4) wanting to stop depot buprenorphine/OAT to use opioids again or feeling ‘cured’ and no longer in need of OAT. Participants were ultimately discussing issues related to clinician-patient power relations, agency and bodily autonomy, and the pursuit of well-being.

Design/methods

Open-ended, semi-structured interviews (n=40)

Keywords

Transitions in care/treatment
Substitution/OAT
About PWUD